Wherever you are on your cancer treatment journey, you may want information on the types of immunotherapy available today. Here we describe some of the different approaches to cancer immunotherapy and how they are used to treat a wide variety of cancers. Please note that these treatments do not include all cancer immunotherapies currently available, but represent some promising approaches that are currently approved by the FDA or being tested in clinical trials.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
In February 2017, Oswald became one of the first patients to receive pembrolizumab (Keytruda®) as first-line therapy for non-small cell lung cancer.
Dr. Kunle Odunsi discusses genomic testing, new treatments, and promising clinical trials in immunotherapy for ovarian cancer.